Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
WO2015110659A1
Methods of immunization with a vaccine inducing a humoral immune response and with a vaccine inducing a cellular immune response
US2017000876A1
Method for the vaccination against HIV
EP3099318A1
Dosage regimen for hiv vaccine
WO2015086738A2
Hiv vaccine
WO2015007337A1
Method for the vaccination against hiv
AU2013273481A1
HIV vaccine
MX2014014683A
Peptides derived from viral proteins for use as immunogens and dosage reactants.
KR20140038364A
Monomeric and multimeric immunogenic peptides
CA2819416A1
Peptide scaffold design
BR112013015985A2
peptide backbone design.
NZ597458A
Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
AU2006235987A1
HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
AU2004200155A1
HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
AU8270601A
Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
HU0303132A2
Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
EA004802B1
This empty document was created automatically and should be filled up and updated.
